The Endocrine Society and Society for Women's Health Research (SWHR®) are co-sponsoring a Congressional briefing on July 10 to examine the need to include more female subjects in preclinical and clinical biomedical research - a move that could revolutionize medical research and scientific discovery.
Although biomedical research drives scientific discovery and innovative medical treatments, it is well known that women and minorities remain underrepresented in most research studies. To truly usher in medical treatments that are tailored to the patient, women and minorities must be reflected in the research studies used to approve new and novel medical treatments.
Scientific findings indicate that women have a much higher rate of adverse effects from approved medical products, and these adverse effects have resulted in some medications being pulled off the market. Scientists must ensure that preclinical research balances the inclusion of males and females and that research on human subjects includes representation from minority populations to appropriately determine how and for what populations the next wave of medical products work.
With limited budget dollars, it is imperative that federally funded research be structured to maximize the value of the investment. At the July 10 briefing, national leaders in women's health and medical research will discuss how to improve scientific understanding of differences between men and women and how these differences impact health.
What: Maximizing the Benefits of Biomedical Research: Why We Need to Balance the Study of Males and Females - A Tale of Mice and Men
Congressional briefing co-sponsored by the Endocrine Society and the Society for Women's Health Research (SWHR®)
Who:
Phyllis Greenberger, MSW
President and CEO, Society for Women's Health Research
Teresa K. Woodruff, PhD
Thomas J. Watkins Memorial Professor of Obstetrics and Gynecology, Northwestern University & Past President of the Endocrine Society
Janine Clayton, MD
National Institutes of Health Associate Director for Research on Women's Health
Director, NIH Office of Research on Women's Health
Marsha B. Henderson, MCRP
Assistant Commissioner for Women's Health, U.S. Food and Drug Administration
Date: Friday, July 10, 2015
12 - 1:30 p.m. (ET)
Where: 1539 Longworth House Office Building
New research explores how omega-3 and omega-6 fatty acids may impact cancer rates